See who's attending

2018 attendees

We were delighted to welcome representatives from the following organisations at the 2018 CEO & Investor Forum.

Adaptimmune  F-star NIHR
Aptus Clinical  FTI Consulting Numis Securities 
Arix Bioscience GlaxoSmithKline Oncimmune
Astex Pharmaceuticals  Globe Life Sciences Oxford BioMedica 
Autifony Therapeutics  GTN  OxSyBio
BioCentury GW Pharmaceuticals  Parkinson's UK
British Business Bank Hammersmith Medicines Research (HMR)  Perella Weinberg Partners
BTG  Horizon Discovery  PetMedix
CellCentric  Immunocore  Polar Capital Partners
Confluence Tax  Instinctif Partners (Life Sciences) PwC
Congenica  IP Group  Scancell 
Consilium Strategic Communications IQVIA SouthWestSensor 
Desktop Genetics Johnson & Johnson Innovation Spirea
Department for International Trade Klein-Edmonds Associates Stratagem IPM 
Diurnal Group  LifeArc Symbiosis Pharmaceutical Services
Downing  LIFNano Therapeutics Syncona Investment Management 
Enesi Pharma  Medherant  Taylor Wessing
Epidarex Capital Medicines Discovery Catapult The Francis Crick Institute
Evox Therapeutics MedImmune  The RSA Group
Exploristics  MediSieve  Therakind 
Exscientia  Mereo BioPharma Group  Thermo Fisher Scientific
Fieldfisher MHRA Tuspark
Financial Times Midatech Pharma University College
Fosun Investment International Mission Therapeutics  University of Cambridge
    VWR International